Pharmaceutical Technology14 小时
Risk adjusted net present value: What is the current valuation of Cardiol Therapeutics’s ...
Cannabidiol 1 is a small molecule commercialized by Cardiol Therapeutics, with a leading Phase II program in Pericarditis.